Effect of Xen Implantation on the Aqueous Humor Proteome
Terminated
- Conditions
- Primary Open Angle Glaucoma
- Registration Number
- NCT04141865
- Lead Sponsor
- Price Vision Group
- Brief Summary
The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma.
- Detailed Description
The purpose of this study is to determine how the aqueous humor proteome changes after implantation of a Xen microstent for treatment of glaucoma using liquid chromatography mass spectrometry.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
- Male or female of any racial or ethnic origin, 18 years or older
- Able to provide written informed consent.
- Scheduled to undergo Xen implantation for open angle glaucoma or already has an aqueous shunt
Exclusion Criteria
- History of conjunctivitis or any ocular infection within the past 3 weeks.
- Any active inflammation of the cornea or the anterior chamber (uveitis)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aqueous humor proteome Change from baseline at 6 months The aqueous humor proteome will be assessed with liquid chromotography/mass spectometry (quantitative LC-MS/MS).
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Price Vision Group
🇺🇸Indianapolis, Indiana, United States
Price Vision Group🇺🇸Indianapolis, Indiana, United States